Skip to content

Clinical trials

Phase 3 Skin Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Skin Neoplasms Phase: Phase 3 Country / region: United States Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20072
20132
20172
20181
20191
20202
20211
20221
20233
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting3
Terminated3
Recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
Pfizer3
Regeneron Pharmaceuticals2
University of Utah2
Agenus Inc.1
Genta Incorporated1
Idera Pharmaceuticals, Inc.1
Iovance Biotherapeutics, Inc.1
M.D. Anderson Cancer Center1
MELA Sciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Skin Neoplasms22
Melanoma17
Neoplasm Metastasis4
Neoplasms3
Skin Diseases2
Basal Cell Carcinoma1
Carcinoma, Squamous Cell1
Sunburn1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.